Condition: Healthy Volunteers
Interventions: Drug: GFB-887; Drug: Placebo
Sponsor: Goldfinch Bio, Inc.
Recruiting
ClinicalTrials.gov: Healthy_Volunteers | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days
Condition: Allergic Contact Dermatitis
Interventions: Drug: Baricitinib; Drug: Placebo
Sponsor: Wright State Physicians
Not yet recruiting
ClinicalTrials.gov: Healthy_Volunteers | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days
May 30, 2019ClinicalTrials.govComments OffHealthy VolunteersAdult | Baricitinib | DelayedType | Efficacy | Healthy | Hypersensitivity | Irritant | Male | Reactions | Skin | Subjects | Treatment | Versus
Condition: Kidney Diseases
Intervention: Diagnostic Test: Kidney MRI
Sponsor: Children’s Hospital Medical Center, Cincinnati
Recruiting
ClinicalTrials.gov: Healthy_Volunteers | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days
Condition: Psoriasis
Interventions: Drug: ABBV-157; Drug: Placebo for ABBV-157
Sponsor: AbbVie
Not yet recruiting
ClinicalTrials.gov: Healthy_Volunteers | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days
May 28, 2019ClinicalTrials.govComments OffHealthy VolunteersABBV157 | Chronic | Evaluate | Healthy | Participants | Pharmacokinetics | Plaque | Psoriasis | Safety | Study | Tolerability | Volunteers
Condition: HIV Infections
Interventions: Biological: Stable CH505TF gp120; Biological: Transient CH505TF gp120; Biological: Glucopyranosyl Lipid Adjuvant-Stable Emulsion (GLA-SE)
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting
ClinicalTrials.gov: Healthy_Volunteers | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days
May 27, 2019ClinicalTrials.govComments OffHealthy VolunteersAdult | Cells | CH505TF | Clinical | Compare | From | gp120 | Healthy | HIV1Uninfected | Immunogenicity | Participants | Produced | Safety | Stably | Tolerability | Transfected | Transiently | Trial
Condition: Safety
Intervention: Biological: PRV-3279 or placebo
Sponsor: Provention Bio, Inc.
Not yet recruiting
ClinicalTrials.gov: Healthy_Volunteers | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days
May 26, 2019ClinicalTrials.govComments OffHealthy VolunteersEvaluate | Healthy | Immunogenicity | Pharmacodynamics | Pharmacokinetics | PRV3279 | Safety | Study | Subjects
Condition: Hypertrophy
Interventions: Behavioral: Resistance exercise; Other: Salmon; Dietary Supplement: Isolated amino acids and fatty acids
Sponsor: University of Illinois at Urbana-Champaign
Recruiting
ClinicalTrials.gov: Healthy_Volunteers | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days
Condition: Healthy Male Participants
Interventions: Drug: AG-881; Drug: [13C315N3]AG-881
Sponsor: Agios Pharmaceuticals, Inc.
Recruiting
ClinicalTrials.gov: Healthy_Volunteers | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days
May 24, 2019ClinicalTrials.govComments OffHealthy VolunteersAdministration | AG881 | Concomitant | Dose | Following | Healthy | Intravenous | Male | Microdose | Oral | Participants | Pharmacokinetic | Safety | Single | Study
Condition: Healthy
Interventions: Drug: PF-04965842; Drug: Probenecid
Sponsor: Pfizer
Not yet recruiting
ClinicalTrials.gov: Healthy_Volunteers | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days
May 23, 2019ClinicalTrials.govComments OffHealthy VolunteersAssess | Effect | Healthy | Metabolites | Participants | PF04965842 | Pharmacokinetics | Probenecid | Study
Condition: Healthy Volunteer
Intervention: Drug: CC-90001
Sponsor: Celgene
Recruiting
ClinicalTrials.gov: Healthy_Volunteers | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days
May 22, 2019ClinicalTrials.govComments OffHealthy VolunteersCaucasian | CC90001 | Healthy | Japanese | MultipleDose | Pharmacokinetics | Safety | Study | Subjects | Tolerability
